Zymeworks (ZYME) Other Non-Current Assets (2021 - 2026)

Zymeworks (ZYME) reported Other Non-Current Assets of $6.7 million for Q1 2026, down 26.87% on a YoY basis from $9.1 million in Q1 2025, and little changed sequentially from $6.7 million in Q4 2025.

Zymeworks (ZYME) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of Other Non-Current Assets data on file, last reported at $6.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 26.87% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (down 26.87% YoY), and the FY2025 full-year result was $6.7 million, down 25.17% from the prior year.
  • Other Non-Current Assets was little changed at $6.7 million in Q1 2026, from $6.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $16.9 million in Q1 2023 to a low of $6.7 million in Q1 2026.
  • A 5-year average of $9.5 million and a median of $7.9 million in 2023 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets climbed 25.93% in 2022 and sank 54.54% in 2024, its largest moves.
  • Tracing ZYME's Other Non-Current Assets over 5 years: stood at $15.7 million in 2022, then tumbled by 51.9% to $7.6 million in 2023, then increased by 17.88% to $8.9 million in 2024, then declined by 25.17% to $6.7 million in 2025, then slipped by 0.33% to $6.7 million in 2026.
  • Business Quant data shows ZYME's Other Non-Current Assets at $6.7 million in Q1 2026, $6.7 million in Q4 2025, and $7.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 1.02 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 14.48 Mn
10 Zymeworks 1.70 Bn 1.34 Bn - 6.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.65 Mn
Dec 31, 2025 6.67 Mn
Sep 30, 2025 7.39 Mn
Jun 30, 2025 8.86 Mn
Mar 31, 2025 9.10 Mn
Dec 31, 2024 8.92 Mn
Sep 30, 2024 7.23 Mn
Jun 30, 2024 7.18 Mn
Mar 31, 2024 7.68 Mn
Dec 31, 2023 7.57 Mn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 7.91 Mn
Mar 31, 2023 16.89 Mn
Dec 31, 2022 15.73 Mn
Sep 30, 2022 16.45 Mn
Dec 31, 2021 12.49 Mn